Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 8/20 | 0.50 |
| ▸ | CTSB | P07858 | 3/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28644179 | 0.92 | CAPN1 (0.50) | CAPN1CTSBOPRM1OPRD1OPRK1 | |
| SCHEMBL28639719 | 0.88 | CAPN1 (0.53) | CAPN1CTSBOPRM1OPRD1 | |
| SCHEMBL14673291 | 0.88 | CAPN1 (0.60) | CAPN1CTSBOPRM1OPRD1OPRK1 | |
| SCHEMBL20477645 | 0.88 | CAPN1 (0.60) | CAPN1CTSBOPRM1OPRD1OPRK1 | |
| SCHEMBL14673292 | 0.88 | CAPN1 (0.60) | CAPN1CTSBOPRM1OPRD1OPRK1 | |
| SCHEMBL28651461 | 0.87 | CAPN1 (0.54) | CAPN1CTSBOPRM1OPRD1OPRK1 | |
| SCHEMBL14682289 | 0.81 | CAPN1 (0.55) | CAPN1CTSBOPRM1OPRD1OPRK1 | |
| SCHEMBL15576934 | 0.81 | CAPN1 (0.55) | CAPN1CTSBOPRM1OPRD1OPRK1 | |
| SCHEMBL14728337 | 0.81 | CAPN1 (0.55) | CAPN1CTSBOPRM1OPRD1OPRK1 | |
| SCHEMBL28630988 | 0.81 | CAPN1 (0.53) | CAPN1CTSBOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113480596-A | Compound for regulating NMDA receptor activity, pharmaceutical composition and application thereof | 北京广为医药科技有限公司 | 2021-10-08 | — | — | CN | claimed |
| CN-110003309-B | Compounds that modulate NMDA receptor activity, pharmaceutical compositions and uses thereof | 北京广为医药科技有限公司 | 2021-09-10 | — | — | CN | claimed |